Although MD2 has been reported to be overexpressed in breast cancer and colon cancer cells to promote proliferation, migration and invasion of tumor cells in recent years (57–59), the expression of MD2, its association with tumor progression and its functional roles in gliomas are unclear. Here, LY96 is linked to breast carcinoma.